Table 1 Radiation agents reviewed in the International Agency for Research on Cancer's (IARC) monograph series
From: Radiation and cancer risk: a continuing challenge for epidemiologists
Agent | Group | IARC Monograph Volume No. | Year |
|---|---|---|---|
Ultraviolet radiation | 1 | 40, 55 | 1986, 1992 |
Radon-222 and its decay products | 1 | 43, 78 | 1988, 2001 |
Ultraviolet radiation A (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from other relevant data) | 2A | 55 | 1992 |
Ultraviolet radiation B (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from other relevant data) | 2A | 55 | 1992 |
Ultraviolet radiation C (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from other relevant data) | 2A | 55 | 1992 |
Solar radiation | 1 | 55 | 1992 |
X- and Gamma (γ)-Radiation | 1 | 75 | 2000 |
Radium-224 and its decay products | 1 | 78 | 2001 |
Radium-226 and its decay products | 1 | 78 | 2001 |
Radium-228 and its decay products | 1 | 78 | 2001 |
Radioiodines, short-lived isotopes, including iodine-131, from atomic reactor accidents and nuclear weapons detonation (exposure during childhood) | 1 | 78 | 2001 |
Radionuclides, α-particle-emitting, internally deposited (NB: Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents) | 1 | 78 | 2001 |
Radionuclides, β-particle-emitting, internally deposited (NB: Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents) | 1 | 78 | 2001 |
Magnetic fields (extremely low-frequency) | 2B | 80 | 2002 |
Magnetic fields (static) | 3 | 80 | 2002 |